{"id":"W2177996735","doi":"10.1016/j.cllc.2015.09.008","title":"A Phase II Trial of Erlotinib and Concurrent Palliative Thoracic Radiation for Patients With Non–Small-Cell Lung Cancer","year":2015,"lang":"en","type":"article","venue":"Clinical Lung Cancer","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":false,"ca_institutions":"Ontario Clinical Oncology Group; Hamilton Health Sciences; University of Toronto; Juravinski Hospital; McMaster University; Princess Margaret Cancer Centre; Juravinski Cancer Centre","funders":"Hamilton Health Sciences; Roche","keywords":"Medicine; Erlotinib; Lung cancer; Oncology; Internal medicine; Cancer; Radiation therapy; Epidermal growth factor receptor","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002456803,0.0001929466,0.0005500176,0.00005245459,0.00008355538,0.00001249836,0.00005817514,0.0001163713,0.00004260241],"category_scores_gemma":[0.0001613609,0.0001362616,0.0001200287,0.000140285,0.0001143435,0.0000842263,0.00003002081,0.000150423,5.852863e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002792322,"about_ca_system_score_gemma":0.001120395,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001277638,"about_ca_topic_score_gemma":0.00009480264,"domain_scores_codex":[0.9984852,0.00005487291,0.0005926471,0.0003893649,0.0002499432,0.0002279404],"domain_scores_gemma":[0.9982661,0.0002572841,0.0004320618,0.0001876593,0.0005475312,0.0003093891],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.0844521,0.01176346,0.6784089,0.0009653799,0.001984566,0.000004101204,0.003599997,0.00007153361,0.0000182756,0.00006412259,0.01744969,0.2012178],"study_design_scores_gemma":[0.8574388,0.0395612,0.06475826,0.001414274,0.01046733,4.714198e-7,0.000277151,0.01092652,0.0004537248,0.00004265062,0.01406668,0.0005929586],"study_design_candidate":"randomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9879514,0.003645355,0.0006485632,0.0005470559,0.00128901,0.005049092,0.0005222465,0.0000239202,0.0003233717],"genre_scores_gemma":[0.9952449,0.0007230652,0.000593817,0.0002975073,0.0006389595,0.00152553,0.0002119954,0.00003507887,0.0007291474],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.7729867,"threshold_uncertainty_score":0.5556589,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.06595579759172852,"score_gpt":0.4888992754225787,"score_spread":0.4229434778308501,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}